Abstract
In Staphylococcus aureus, vancomycin‐resistance‐associated response regulator (VraR) is a part of the VraSR two‐component system, which is responsible for activating a cell wall‐stress stimulon in response to an antibiotic that inhibits cell wall formation. Two VraR‐binding sites have been identified: R1 and R2 in the vraSR operon control region. However, the binding of VraR to a promoter DNA enhancing downstream gene expression remains unclear. VraR contains a conserved N‐terminal receiver domain (VraRN) connected to a C‐terminal DNA binding domain (VraRC) with a flexible linker. Here, we present the crystal structure of VraRC alone and in complex with R1‐DNA in 1.87‐ and 2.0‐Å resolution, respectively. VraRC consisting of four α‐helices forms a dimer when interacting with R1‐DNA. In the VraRC–DNA complex structure, Mg2+ ion is bound to Asp194. Biolayer interferometry experiments revealed that the addition of Mg2+ to VraRC enhanced its DNA binding affinity by eightfold. In addition, interpretation of NMR titrations between VraRC with R1‐ and R2‐DNA revealed the essential residues that might play a crucial role in interacting with DNA of the vraSR operon. The structural information could help in designing and screening potential therapeutics/inhibitors to deal with antibiotic‐resistant S. aureus via targeting VraR.
Keywords: DNA binding domain, NMR, response regulator, Staphylococcus aureus, two‐component system, vancomycin resistance, x‐ray crystal structure
Short abstract
1. INTRODUCTION
The emergence of antibiotic‐resistance mechanisms from infection‐causing microbes is a threat to the treatment of diseases. 1 , 2 , 3 Among antibiotic‐resistant microorganisms, the group of so‐called ESKAPE bugs—Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species—was found responsible for severe nosocomial infections. 4 , 5 , 6 In particular, methicillin‐resistant S. aureus (MRSA) infection is often implicated in most cases of hospitalized infections. 7 , 8 , 9 , 10 Specifically, the Mu50 MRSA strain is vancomycin‐resistant. 11 , 12 The introduction of antibiotics leads to a cell wall stress stimulon in vancomycin‐resistant S. aureus infection. 13 , 14
To cope with environmental stress, these bacteria sense the stress and respond, thereby becoming more resilient. One major contributor to signaling mechanisms acts via a two‐component signal (TCS) transduction system. 15 , 16 The TCS is based on a conserved phosphotransfer pathway between histidine kinase (HK) and its response regulator (RR). Typically, the response regulator contains a receiver domain (RD) and a DNA‐binding domain (DBD) connected with a linker. 17 , 18 The autophosphorylation of HK leads to an active phosphoryl group, which is transferred to the conserved Asp residue on the RD of RR. 17 Furthermore, phosphorylation of RRs often leads to structural changes and enhances binding to its promoter DNA. 19 , 20 , 21
In S. aureus, the vancomycin resistance‐associated sensor/regulator (VraSR) TCS comprises HK (VraS) and RR (VraR), which recognize and transduce cell wall stress. 14 , 22 , 23 In addition to vancomycin resistance, the VraSR system was demonstrated as a “central regulation factor” for its involvement in regulating virulence. 24 S. aureus VraR belongs to the NarL/FixJ family, which is characterized by a typical helix‐turn‐helix (HTH) structural motif at the C‐terminal DNA binding domain. 25 The phosphorylated VraR binds to promoter DNA and increases the expression of the vraSR operon and the regulation of additional genes responsible for cell wall synthesis. 14 , 20 , 26 Two VraR‐binding sites, R1 and R2, in the vraSR operon control region have been identified. 20 However, the detailed mechanism of VraR binding to promoter DNA for regulating downstream gene expression is still unclear.
The structural changes upon the activation of full‐length RRs have been moderately understood. 17 , 27 Previous studies demonstrated that VraR predominantly exists as a monomer and is induced to form a dimer by phosphorylation, which allows for extended DNA recognition. 20 , 21 , 28 The crystal structure of VraR revealed a closed conformation between its RD and DBD in the un‐phosphorylated form, whereas the presentation of beryllofluoride (BeF3 −) for VraR activation leads to an open conformation and promotes dimerization. 28 VraR phosphorylation leads to the opening of a hydrophobic pocket at the RD in which the Met13 residue of one protomer protrudes into its opposite protomer. 28 A recent study showed that the substitution of a single residue Met13 with alanine greatly inhibited the dimer formation and suggested that any effort to hamper the phosphorylation‐induced dimerization can disrupt cell wall stress in S. aureus. 29
Here, we report the crystal structure of VraRC in complex with R1‐DNA elaborating clear and potent binding interactions. The complex structure shows a compact dimer between DBDs when binding to R1‐DNA. The positively charged surface (α9 helix) of VraRC compliments the negatively charged DNA phosphodiester backbone. Also, the complex structure of VraRC–DNA contains six Mg2+ ions, two of which coordinated with Asp194 of each subunit. Further analysis with biolayer interferometry assay (BLI) revealed that the presence of Mg2+ ion increased the binding affinity of VraRC toward DNA. Our study revealed the atomic molecular interactions of VraRC to promoter DNA with solid biophysical and biochemical evidence.
2. RESULTS
2.1. Characterization of VraR in solution
We constructed and purified the recombinant full‐length VraR (residues 1–209) and VraRC (residues 138–209). From the elution profiles of size‐exclusion chromatography along with the calibrated standard protein markers, both VraR and VraRC eluted as monomers with a molecular weight 23.56 and 8.33 kDa, respectively. The high purity of samples was assessed (> 95%) on Coomassie‐blue‐stained SDS‐polyacrylamide gel (Figure S1). A previous report showed that the phosphorylation of VraR was mimicked with BeF3 − and led to a stable dimer. 28 Here, we followed a similar procedure by incubating VraR with 5 mM BeF3 − for activation and validated the dimer formation via analytical ultracentrifugation–sedimentation velocity (AUC‐SV) (Figure S2). The circular dichroism (CD) spectra for VraRC, inactive and active forms of VraR in 20 mM sodium phosphate, pH 6.0, at 25°C showed well‐folded conformations with a typical far‐UV spectrum and negative signals at 222 and 208 nm and a positive signal at 193 nm, which indicates a classical helical structure (Figure S3). The thermal unfolding experiments were performed with CD spectroscopy for VraRC, inactive and active VraR in 20 mM sodium phosphate, at pH 6.0, 7.0, and 8.0. VraRC monitored at 222 nm was most stable at pH 6.0, with melting temperature 58.3°C (Table S1). A moderately higher thermal stability for active VraR at 52.17°C than the inactive VraR at 48.82°C agrees with previous findings. 30
To understand the stoichiometry of both inactive and active VraR toward R1‐DNA DNA, we analyzed the complex formation by using AUC‐SV. Equimolar ratios of active VraR with R1‐DNA mixture displayed two peaks in a sedimentation coefficient [c(S)] distribution plot with 2.69 and 5.07 Svedberg (S) (Figure 1). The unbound R1‐DNA was observed in the first peak at 2.69 S, whereas the second peak at 5.07 S corresponds to ~64.5 kDa, which is close to the theoretical molecular weight of dimerized active VraR (47.12 kDa) in complex with R1‐DNA (18 kDa). Our finding for inactive VraR to R1‐DNA in AUC‐SV resulted in a peak at 2.7 S corresponding to ~23.3 kDa, indicating both inactive VraR and unbound DNA. However, the anticipated inactive VraR‐DNA complex at 5.2 S displayed a minor peak, suggesting a partial complex formation.
FIGURE 1.

AUC‐SV profiles showing sedimentation coefficient distribution. All the data were analyzed by using Sedfit for assessing molecular weights. (a) The c(S) distribution of unbound R1‐DNA is at 2.69 S and active VraR in complex with R1‐DNA had a peak shift at 5.07 S. (b) The c(S) distribution of inactive VraR and unbound R1‐DNA are at 2.7 S and a minor peak at 5.2 S for inactive VraR–DNA complex
2.2. Crystal structure of VraRC and its dimerization with R1‐DNA complex
In this study, VraRC was crystalized alone and in complex with its promoter DNA. The VraRC crystal structure was solved to a resolution of 1.87 Å by the molecular replacement method with VraR as a model (PDB ID: 4GVP). VraRC, consisting of four α‐helices designated α7, α8, α9 and α10 (Figure S4), was validated to have an identical conformation when aligned to the DBD of full‐length inactive VraR with root mean square deviation (RMSD) of 0.31 Å. To recognize the atomic basis for specific DNA recognition by VraRC, we performed crystallization trials with various lengths of double‐stranded R1‐ and R2‐DNAs, including the blunt end or sticky end of one base (Table S2). Only R1‐DNA with 22 bp was successful in multiple crystallization trials with VraRC. The co‐crystal structure of VraRC in complex with R1‐DNA was solved to a resolution of 2.0 Å in space group‐R3 by using the molecular replacement method. All the crystallographic and refinement statistics are in Table S3. An asymmetric unit consists of two VraRC subunits with electron density available from Glu143‐Ile208 and R1‐DNA nucleotides (5′‐AGACTAAAGTATGAACATC‐3′) near the protein‐bound region. In the VraRC‐DNA complex, the dimerization interface of two α10 helices between VraRC subunits allows for compact dimer formation when binding to R1‐DNA (Figure 2a). Specifically, three hydrogen bonds formed between residues Thr196‐Thr196, Gly162‐Gln197 and Gln197‐Gly162 among two α10 subunits of VraRC.
FIGURE 2.

Structural overview of VraRC in complex with promoter DNA. (a) Upstream and downstream binding of two VraRC subunits binding to R1‐DNA are shown in blue and orange, respectively. Secondary structural elements on both the subunits are labeled and six Mg2+ ions are in green spheres. (b) Schematic diagram showing detailed interactions between two VraRC molecules and DNA. Hydrogen bonds, electrostatic interactions are shown in green and brown dotted lines
Structural alignment between the VraRC dimer from the R1‐DNA complex and domain‐swapped dimer of full‐length active VraR (PDB ID:4IF4) revealed high similarity, with an RMSD of 0.56 Å. However, the superimposition of a single subunit caused slight rotation in the second subunit (Figure 3). The distance of two Lys177 residues from the DNA‐bound VraRC dimer was 31.6 Å as compared with 33.6 Å for the active VraR DBD, which suggests that both α9 helices move closer when interacting with DNA. Moreover, the buried surface area between the dimer interface of the VraRC–DNA complex and active VraR DBD was 443.75 and 420.3 Å, respectively. Also, the superimposition of two VraRC subunits from an asymmetric unit of the VraRC–DNA complex had an RMSD of 0.09 Å. The above assessment showed no significant conformational changes within the VraRC dimerization upon DNA binding.
FIGURE 3.

Superimposition of VraRC from the R1‐DNA complex in yellow and activated VraR DBD (PDB ID: 4IF4) in light‐cyan. The Subunit‐B has slight rotation upon binding to DNA. Lys177 and Lys180 in the VraRC dimer from α9 helices are involved in binding to DNA are shown as sticks. Distances between two Lys177 and two Lys180 residues within DNA‐bound VraRC dimers were 2.2 and 1.0 Å closer than active VraR
2.3. Major and minor groove interactions of VraRC –DNA complex
In the VraRC–DNA complex structure, R1‐DNA presents a β‐form conformation with base stacking interactions between the two complementary DNA strands. Eleven nucleotides from the DNA duplex had hydrogen and salt bridge interactions with the VraRC dimer (Figure 2b). Similar to the other complex structures of the NarL/FixJ family, both the α9 helices from each VraRC subunit are inside the DNA major groove. Of six residues (Thr149, Arg151, Thr175, Thr178, Thr181, and His182) binding to the DNA major groove (T5′T6′C7′A8′), three threonine's (Thr175, Thr188, and Thr181) interact with C7′ alone. Mutations of corresponding C7′ and C11′ to T reduced the binding affinities of inactive and active VraR by ~6‐ and threefold toward R1‐DNA. 20
Four residues from each VraRC subunit, Asn165, Lys180, Ser184, and Arg195, interact with the DNA minor groove (A8G9T10 in one half‐site and A15′G16′T17′ in the other half‐site). Ser184 binds to T10 via a hydrogen bond with distance of 2.7 Å. Residue Asn165 of α8 contacts A8 with a hydrogen bond (3.1 Å) along with two water‐mediated hydrogen bonds toward A8 and G9. Both oxygen atoms of G9 phosphate bind to Arg195 with hydrogen‐bond and salt‐bridge interactions (2.7 and 2.8 Å). Furthermore, Lys180 bind to oxygen and nitrogen atoms of the G9 base. A previous study showed a sevenfold decrease in binding affinity between inactive VraR and a sixfold decrease for active VraR toward R1‐DNA when nucleotides G9 and C4 were mutated to T20. Since Lys180 and Arg195 form two bonds with G9, these two residues might play a crucial role in recognizing R1‐DNA.
2.4. NMR study reveals fewer VraRC residues interacting with R2‐DNA than R1‐DNA
A previous study presented the NMR backbone assignment of VraRC from Leu144‐Gln209 with six missing residues (Glu150, Arg151, Asn165, Gln166, His173, and Ile176). 30 By contrast, all the amide resonances except for Lys139 and Asn165 were unambiguously assigned for VraRC in this study (Figure S5). Furthermore, triple‐labeled samples of full‐length VraR in both inactive and active forms were prepared, and 2D 1H15N TROSY‐HSQC spectra were obtained. Increasing the protein concentration to >0.3 mM resulted in heavy precipitation, which hampered our trials for VraR backbone assignment. In comparison, the 2D 1H15N TROSY‐HSQC spectra of active VraR showed more and well‐dispersed cross peaks than the inactive form (Figure 4). Accordingly, active VraR showed better solubility and stability than the inactive VraR at pH 6.0, which is consistent with the results of thermal denaturation experiments. The 2D 1H15N TROSY‐HSQC spectra of VraRC were overlaid on inactive and active VraR. Crucial residues from the C‐terminal domain (Glu191 and Gln204) responsible for closed interface with N‐terminal domain of inactive VraR and the residues attributed to DBD dimerization (Gly162, Thr196, and Gln197) in active VraR were declared on VraRC assignment (Figure 4). Although the backbone assignment of the full‐length VraR is unobtainable, the overall cross peaks of VraRC are similar to both active and inactive forms of VraR.
FIGURE 4.

(a) The overlaid 2D 1H, 15N TROSY‐HSQC spectra were acquired from inactive VraR (blue) and VraRC (red). Residues Gln204 and Glu191 of α10 helix that interact with the N‐terminal domain of inactive VraR are labeled on VraRC. (b) The overlaid 2D 1H, 15N TROSY‐HSQC spectra were acquired from active VraR (blue) and VraRC (red). Residues Gly162, Thr196 and Gln197 involved in the DBD dimer of active VraR are labeled on VraRC. All samples were prepared at pH 6.0 and acquired spectra at 298 K
We used NMR to analyze the binding interface of VraRC toward both R1‐ and R2‐DNA by chemical shift perturbations (CSPs). The weighted 1H–15N chemical shift differences were measured and charted from HSQC spectra of VraRC with both R1‐DNA (Figure 5a) and R2‐DNA (Figure 5b). VraRC titrated with R1‐DNA showed a greatly perturbed result for the residues Arg151, Ala169, Thr176, Lys177, Lys180, Ser184, Asp194, Ala198, and Phe203. The largest chemical shift changes were mapped on the VraRC structure (Figure 5c). Of note, detected residues of CSPs with R1‐DNA agreed with the interactions found in the crystal structure of the VraRC–DNA complex. However, VraRC titrated with R2‐DNA showed less perturbed residues than R1‐DNA. In particular, residues Lys177 and Thr178 from the α9 helix were crucial in binding to the major groove of R1‐DNA but did not show any perturbation upon titrating with R2‐DNA. Perturbed residues from VraRC titration with R2‐DNA mapped on VraRC structure showed fewer residue involvement on binding to R2‐DNA (Figure 5d). A previous study showed that R1‐ and R2‐DNAs have two binding sites; however, R1‐DNA is a quasi‐palindromic sequence (−66AGACTAAAGTATGAACATCATT−49) with a single nucleotide separating two putative binding sites, whereas R2‐DNA has four additional nucleotides in between the first and second binding sites (−47GTTCCGGAGCCTATTCATATTGGTT−22). 20 Possibly the low sequence similarity and distance between binding sites for R1‐ and R2‐DNA may result in the disparity in VraRC titrations.
FIGURE 5.

Interaction of VraRC with both R1‐ and R2‐DNAs inspected by NMR titrations. Plots of the normalized chemical shift perturbations of VraRC after binding to R1‐DNA (a) and R2‐DNA (b). Gaps indicate the missing peaks from DNA titration. Perturbed residues with values >0.06 (dotted black line) mapped on the structure of VraRC for both (c) R1‐DNA and (d) R2‐DNA titrations
2.5. The presence of Mg2+ ion enhances VraRC –DNA binding affinity
The crystal structure of the VraRC–DNA complex consists of Mg2+ ion bound to Asp194 in both protomers (Figure 6). Mg2+ ion was not added to VraRC in any of the purification steps nor in complex formation with DNA; however, the crystallization condition contains 200 mM MgCl2. The electron density available near Asp194 was filled with Mg2+, which is coordinated with five water molecules. Each Mg2+ ion binds to the OD2 of the Asp194 side chain in two subunits, with distances of 2.0 and 2.1 Å. The built structure with Mg2+ ion was assessed by using the CheckMyMetal server 31 , 32 to confirm the acceptable coordination interactions. To evaluate the importance of Mg2+ in binding affinity for VraRC toward R1‐DNA, we performed BLI experiments in the presence and absence of Mg2+. The purified VraRC was treated with 0.5 mM ETDA for chelating non‐specific metal bindings and finally buffer exchanged to 20 mM Bis‐Tris, 80 mM NaCl at pH 6.0. The binding affinity of VraRC toward R1‐DNA was 3.71 μM in the absence of Mg2+ ions (Figure 7a). Of note, the addition of 10 mM MgCl2 to VraRC increased the binding affinity to 0.47 μM (Figure 7b).
FIGURE 6.

Mg2+ ions shown as green spheres binding to Asp194 of two subunits in the VraRC–DNA complex. Subunits are shown in orange and blue. Each Mg2+ ion has a hydrogen bond interaction to the OD2 atom of Asp194 with a distance of 2 Å and 2.1 Å. Five water molecules coordinating the Mg2+ ions are in red spheres. The 2Fo‐Fc electron density map of Asp194, water molecules and Mg2+ ions was contoured at 1σ and shown as a blue mesh
FIGURE 7.

R1‐DNA binding affinity of VraRC at different concentrations measured with BLI technology both in the absence (a) and presence (b) of 10 mM MgCl2. All data were processed and analyzed by a double reference subtraction method by using Octet Data Analysis Software. The 2:1 binding model of association and dissociation function was used to determine K d in the global fitting. (c) The electrostatic potential surface of VraRC was calculated with the Pymol plugin APBS, showing red for the negative surface and blue for the positive charge surface. A slight negative charge appearing near the side chain of Asp194 was labeled. (d) Thermal denaturation curves of VraRC–DNA complex in the presence (blue) and absence (red) of 10 mM MgCl2 were monitored at 222 nm, revealing melting temperatures of 61.0 and 56.3°C, respectively
The electrostatic potential around the residues complementing DNA binding in the VraRC dimer displayed a predominant positively charged surface (Figure S6). However, at the site of the minor groove interaction, the surface shows a partial negative charge from the carboxylic acid group of Asp194 (Figure 7c). The positively charged Mg2+ ion bound to Asp194 may cooperate with DNA binding. Also, we tested the thermal denaturation of the VraRC–DNA complex in the absence and presence of Mg2+ ions. Although the denaturation curve became less cooperative with the addition of Mg2+ to the VraRC–DNA complex, we observed a moderate increase in melting temperature from 56.3 to 61.0°C (Figure 7d). Apart from the two Mg2+ ions bound to Asp194, four Mg2+ ions were observed in the VraRC–DNA complex structure, with two having no direct contact with the nucleotides and coordinated by six water molecules (Figure S7). The remaining two Mg2+ ions are bound to nucleotides C4 and C11′. Each Mg2+ ion was interconnected to each phosphate oxygen atom of two cystine nucleotides from nearby asymmetric units (Figure 8). Such a phenomenon might result from crystal contacts as well.
FIGURE 8.

Packing within the crystal of VraRC–DNA complex is shown among three asymmetric units in pink, blue and yellow. Crystal contacts of DNAs were observed between two C4–C4 and C11′–C11′ nucleotides. The detailed Mg2+ ions interaction within two asymmetric units between DNAs are in boxes. Each Mg2+ ion (green spheres) binds with OP1 (asymmetric unit1) and OP2 (asymmetric unit2) atoms of C4 nucleotides with 2.0 and 2.1 Å and are surrounded by water molecules (red spheres)
3. DISCUSSION
In S. aureus, VraR plays a substantial role in regulating several genes, which leads to a thick cell wall under stressful conditions. 14 , 22 Exploring VraR interaction behavior toward its cognate DNA might shed light on its action mechanism. Here, we present the crystal structure of the VraRC–DNA complex consisting of two VraRC molecules binding with R1‐DNA as a compact dimer. Structural alignments between the VraRC–DNA complex and the crystal structures available from the same family of RRs, such as LiaR from Enterococcus faecalis, 33 DosR from Mycobacterium tuberculosis 34 and NarL from Escherichia coli, 35 showed similar binding orientations, with RMSDs of 0.33, 0.91, and 0.98 Å, respectively.
The dimerization of active VraR with conformational flexibility in the linker region leverages its DBD to specific DNA recognition. 28 A previous study showed that both inactive and active VraR interacts with R1‐DNA. 20 Our AUC‐SV experimental analysis with Sedfit resulted in a molecular weight of ~64.5 kDa for active VraR with R1‐DNA, thus further validating the dimer formation in the complex. In contrast, the AUC‐SV results for inactive VraR and R1‐DNA indicated a partial complex formation. To understand the probable characteristics of inactive VraR with R1‐DNA, we overlaid the structure of VraR (PDB ID: 4GVP) and the VraRC–DNA complex (Figure S8). Although all residues from the inactive VraR DBD fit well in the structural superimposition, the complex formation of inactive VraR and R1‐DNA was minimal on AUC‐SV analysis. The inaccessibility of the α10 helix in inactive VraR (because of closed conformation) might hamper the dimerization during the complex formation with R1‐DNA. Predominantly, the α10 helix is involved in dimerization from the available DBD‐DNA crystal structures in the NarL/FixJ family. 33 , 34 , 35 Certainly, we cannot rule out that inactive VraR binding to DNA could promote an active‐like conformation or in tandem repeats, as observed in PhoP from the OmpR family RR. 36
In RRs, Mg2+ ion plays a vital role in phosphorylation because it is susceptible to binding oxygen atoms mainly from the side‐chain carboxylates of conserved Asp residues typically in the RDs. Here, we report that two Mg2+ ions bound to each Asp194 in the VraRC–DNA complex, and this is the first crystal structure showing the Mg2+ ions in DBD‐DNA structures from the NarL/FixJ family. Asp194 is a conserved residue in LiaR, and mutation of the corresponding Asp position to Asn significantly increased the binding affinity toward its promoter DNA. 33 Also, the BLI assay showed an approximately eightfold increase in binding affinity for VraRC toward R1‐DNA in the presence of MgCl2. In addition, the crystal of VraRC alone was grown with 200 mM MgCl2 in crystal condition, but we found no indication of Mg2+ ion density map near Asp194. Thus, the Mg2+ ion might prefer binding to Asp194 only in the presence of DNA. Nevertheless, further validation of the Mg2+ ion role in VraRC is needed.
4. CONCLUSIONS
Here, we describe the crystal structure of VraRC from S. aureus in complex with its promoter DNA. Our crystal structure with biophysical analysis supports the binding of activated VraR to R1‐DNA in dimer formation. NMR titrations of VraRC toward R1‐DNA also confirm the crucial residues in binding to R1‐DNA and agree with the crystal structure of the VraRC–DNA complex. We also report the involvement of Mg2+ ion in the VraRC–DNA complex, which was not present in the crystal structure of VraRC despite adding Mg2+ ions during crystallization. Mg2+ ion might play a vital role in VraRC, binding to Asp194 in the presence of DNA and increasing the binding affinity.
5. MATERIALS AND METHODS
5.1. Expression and purification of VraR and VraRC
The gene encoding full‐length VraR (residues 1–209) or VraRC (residues 138–209) was PCR‐amplified from the genomic DNA and cloned into the pET‐GB1 or pET29b (Novagen) vector with Nde I and Xho I restriction sites to obtain the recombinant protein with a C‐terminal His‐tag. All proteins were overexpressed in E. coli BL21(DE3). For labeled (15N, 15N/13C, and 15N/13C/2H) protein samples, the cells were grown in H2O‐ or D2O‐containing M9 minimal medium containing 15NH4Cl (1 g/L) and 13C‐glucose (2 g/L) at 37°C. When OD600 readings reached 0.6, the cells were induced with 0.5 mM IPTG for VraR or 0.6 mM IPTG for VraRC, then grown for an additional 4 hr. The cultured cells were pelleted down at 6000 rpm for 20 min. The cultured cells were lysed by using a microfluidizer in binding buffer (20 mM Tris–Hcl pH 8.0, 500 mM NaCl, 2% glycerol) and purified by nickel‐nitrilotriacetic acid (Ni‐NTA) affinity chromatography. Furthermore, the target protein was dialyzed and concentrated with buffer (20 mM Bis‐Tris pH 6.0, 80 mM NaCl, 2% glycerol) and purified with a size exclusion column (Superdex75 10/300). The purity of the recombinant proteins was verified on SDS‐PAGE. Protein concentration measurement was quantified by the BCA method according to the protocol provided by the manufacturer, using bovine serum albumin as a standard.
5.2. Double‐stranded DNA preparation and formation of complex with VraR
The single‐stranded DNAs of R1 and R2 from the vraSR operon were purchased from MDBio Inc. (Taiwan). For preparing double‐stranded DNA, equal amounts of two complementary deoxynucleotides were mixed, followed by heating at 95°C for 10 min and a slow cool‐down to room temperature. Phosphorylation of aspartate in RRs can be mimicked by using beryllofluoride. 37 Leonard et al. showed the stable formation of VraR homodimerization upon treatment with BeF3 −28. VraR was incubated with 5 mM BeF3 − overnight at room temperature, and the activated protein was titrated with dsDNA in a 2:1 ratio. Crystallization of the VraRC–DNA complex involved using a 2:1 ratio of two VraRC molecules to one R1‐DNA duplex.
5.3. VraRC with/without R1‐DNA (22‐bp) complex crystallization
Protein crystallization involved using the vapor diffusing method at 20°C. VraRC formed crystals with 100 mM Tris–Hcl, pH 8.5, 16% PEG4000 (w/v), and 200 mM MgCl2 with the sitting drop vapor diffusion technique. The crystallization conditions for VraRC with R1‐DNA (22 bp) were screened by the hanging drop vapor diffusion technique. The crystallization drop of VraRC or VraRC–DNA at 7 mg/ml consisted of 1 μl with an equal volume of mother liquor. Crystals of VraRC–DNA were grown for 4–7 days with optical conditions of 100 mM sodium cacodylate, pH 6.6, 10% PEG1500 (w/v), 5% PEG400 (w/v), and 200 mM MgCl2. All crystals were cryoprotected with the addition of 15% to 25% glycerol in mother liquor and flash‐frozen in liquid nitrogen. X‐ray diffraction data were collected from beamline 05A at the National Synchrotron Radiation Research Center (Hsinchu, Taiwan). All diffraction data were indexed, integrated, and scaled by using HKL2000. 38 The crystal structures were determined by molecular replacement in the PHENIX Phaser, 39 with the VraR crystal structure (PDB ID: 4IF4) used as the search model. All initial models were manually rebuilt by using the program Coot 40 and then refined in PHENIX. 41 Figures related to protein structures were generated by using Discovery Studio visualizer and PyMOL. 42
5.4. CD spectroscopy
All CD spectra were collected by using a Chirascan‐plus qCD spectrometer (Applied Photophysics, Surrey, UK). Protein samples are prepared in 20 mM sodium phosphate, at pH 6.0, 7.0 and 8.0. The far‐UV spectra were acquired at 25°C with 15–20 μM protein samples in a 1‐mm path‐length cuvette. The signals from 195 to 260 nm were recorded three times with a scan rate of 20 nm/min and a bandwidth of 1 nm after subtracting the blank signals from a solvent. Equilibrium thermal‐denaturing experiments were obtained by measuring the change of CD signal at 222 nm from 25 to 95°C at a rate of 1°C/min with a 1°C interval.
5.5. Biolayer interferometry
We used the ForteBio Octet RED96 system, and the experimental conditions were performed at 25°C. 5′‐biotinylated 25‐bp R1‐DNA was prepared in assay buffer (20 mM Bis‐Tris and 80 mM NaCl at pH 6.0) and immobilized onto streptavidin biosensor tips. BLI signals were measured for the immobilized response, followed by the association of VraRC at different concentrations (10, 5, 2.5, 1.25, 0 μM) and subsequent dissociation into blank assay buffer. Octet Data Analysis software was used for processing the collected data with a double reference subtraction method. The dissociation constant (K d) was obtained by fitting with a 2:1 binding model of association and dissociation functions with the global fit.
5.6. NMR spectroscopy and data processing
The NMR sample of VraRC (at 0.6 mM) was prepared in buffer containing 20 mM sodium phosphate, 50 mM NaCl and 1 mM NaN3 at pH 7.0. The NMR spectra were acquired at 310 K on Bruker AVANCE 600, 800, and 850‐MHz spectrometers equipped with a z‐gradient TXI cryoprobe (Bruker, Karlsruhe, Germany). 3D triple‐resonance experiments of HNCO, HN(CA)CO and HNCACB spectra were performed with a 15N/13C/2H‐uniformly labeled protein sample in H2O for backbone resonance assignments of VraRC. Briefly, we used the mixture of 10% 13C‐glucose and 90% unlabeled glucose as the carbon source for the expression of the VraR sample and analysis of the distribution of 13C labels of the methyl groups in Leu and Val residues on a 2D 1H, 13C HSQC spectrum. The weighted CSPs for backbone 15N and 1HN resonances were calculated by the equation Δδ = [((ΔδHN)2 + (ΔδN/5)2)/2]0.5 and for methyl 13C and 1H resonances by the equation Δδ = [((ΔδH)2 + (ΔδC × 0.3)2)/2]0.5. For Leu and Val residues, the methyl CSP was the mean value of two methyl groups. All NMR spectra were processed by using Bruker TopSpin 4.0 or NMRPipe 43 and analyzed by using NMRView. 44
5.7. Analytical ultracentrifugation
Highly purified samples of inactive VraR (20 mM Bis‐Tris pH 6.0, 100 mM NaCl) and active VraR (20 mM Bis‐Tris pH 6.0, 100 mM NaCl, 5 mM BeF3 −, 5 mM MgCl2) were used for AUC‐SV experiments on Beckman Coulter ProteomeLab XL‐1 ultracentrifuge. Approximately 20 μM inactive or active VraR mixed with R1‐DNA (30 bp) was loaded to An‐50TI rotor, and data collection was performed at 50,000 rpm and 280 nm under 20°C. SednTrep and SedFit were used for processing and analyzing the data.
5.8. Additional information
The atomic coordinates and structure factors of VraRC, VraRC‐DNA complex and VraRN were deposited in the RCSB Protein Data Bank (PDB ID: 7VE4, 7VE5, and 7VE6). The backbone NMR chemical shifts of VraRC were deposited in the Biological Magnetic Resonance Data Bank (accession no.: 51095).
CONFLICT OF INTEREST
The authors declare that there is no conflict of interest regarding the publication of this paper.
AUTHOR CONTRIBUTIONS
Jangam Vikram Kumar: expression, purification and crystallization of protein–DNA complex, determining the crystal structures, manuscript writing; Tien‐Sheng Tseng: crystallization and AUC‐SV experiments; Yuan‐Chao Lou: NMR backbone assignment; Shu‐Yi Wei: cloning, NMR CSP experiments; Tsung‐Han Wu: CD data analysis, Hao‐Cheng Tang: BLI data acquisition and analysis; Yi‐Chih Chiu: X‐ray diffraction data collection and processing; Chun‐Hua Hsu: validation and Funding; Chinpan Chen: conceptualization, project administration, funding, supervision and manuscript writing.
Supporting information
Table S1 Thermal stability of VraRC, VraR, and BeF3 − activated VraR in sodium phosphate buffer at the different pH values monitored at 222 nm by CD spectroscopy.
Table S2. DNA sequences used for binding and co‐crystallization with VraRC. Potential binding nucleotide sites to the DNA binding domain identified from the previous study are underlined.
Table S3. Data collection and structural refinement statistics for VraRC, VraRC–DNA complex and VraRN. Data were collected on a single crystal for each dataset.
Figure S1 The purified VraRC and VraR on 15% SDS‐PAGE. Lane 1, unlabeled VraRC; lane 2, 15N13C2H VraRC; lane 3, VraR; lane 4, 5N13C2H VraR.
Figure S2 The AUC‐SV profiles showing the dimer formation of VraR with BeF3 − activation. The c(S) distribution of inactive VraR is at 2.8 S and BeF3 − activated VraR at 3.45 S.
Figure S3 (A) Far‐UV CD spectra for VraRC, VraR and VraR activated by BeF3 − in sodium phosphate buffer at pH 6 at 25°C. (B) The thermal unfolding experiments of VraRC, inactive and active VraR are monitored at 222 nm reveal melting temperatures of 58.30, 48.82, and 52.17°C.
Figure S4 The crystal structure of VraRC contains residues Glu143 to Gln209 and all α‐helices are labeled accordingly.
Figure S5 2D 1H–15N HSQC spectra for VraRC at pH 7.0 and 310 K. All backbone resonances were identified and labeled except for the amide resonances of Lys139 and Asn165. The side chain NH2 resonances of Asn and Gln are connected by blue horizontal lines.
Figure S6 The electrostatic potential surface of two VraRC subunits from the VraRC–DNA complex having a predominantly positive charge favorable for DNA interactions. The electrostatic potential was calculated with Pymol plugin APBS, showing red for negative and blue for positive surface.
Figure S7 In the VraRC–DNA complex, 4 Mg2+ ions (green spheres) are present near DNA. Two Mg2+ ions having no direct interactions with DNA are in black circles. Six water molecules coordinating each Mg2+ ion are in red spheres.
Figure S8 Structural overlay of inactive VraR (PDB ID: 4GVP) (yellow) toward a single subunit of VraRC (blue) from the R1‐DNA complex. All 11 residues binding to R1‐DNA from the VraRC–DNA complex are depicted as sticks on inactive VraR to show the probability of a binding pattern as the α9 helix fits into the major groove DNA.
ACKNOWLEDGMENTS
We are thankful for access to the synchrotron radiation beamline 05A at the National Synchrotron Radiation Research Center (NSRRC) in Taiwan. We also acknowledge acquisition of NMR spectra at the High‐field Biomacromolecular NMR Core Facility, Academia Sinica, supported by Core Facilities for Protein Structural Analysis from the National Research Program for Biopharmaceuticals (NRPB). We are thankful to Tsunai Yu for assistance with NMR data acquisition. We thank the Dr. Mou Kurt Yun laboratory for providing the BLI instrument and assisting in analysis. We acknowledge the use of the Chirascan‐plus qCD spectrometer and are thankful to Kun‐Hong Chen for AUC‐SV data collection at the Biophysics Core Facility, funded by the Academia Sinica Core Facility and Innovative Instrument Project (AS‐CFII‐108‐111). This work was supported by Academia Sinica (104‐0210‐01‐09‐02) and the Ministry of Science and Technology, Taiwan, ROC (MOST 105‐2320‐B‐001‐019‐MY3 and MOST 108‐2311‐B‐001‐016‐MY3 to Chen Chinpan and MOST 110‐2628‐B‐002 ‐049 and 110‐2113‐M‐002 ‐023 to Chun‐Hua Hsu).
Kumar JV, Tseng T‐S, Lou Y‐C, Wei S‐Y, Wu T‐H, Tang H‐C, et al. Structural insights into DNA binding domain of vancomycin‐resistance‐associated response regulator in complex with its promoter DNA from Staphylococcus aureus . Protein Science. 2022;31(5):e4286. 10.1002/pro.4286
Review Editor: Hideo Akutsu
Funding information Academia Sinica, Grant/Award Number: AS‐CFII‐108‐111; MOST, Grant/Award Numbers: 105‐2320‐B‐001‐019‐MY3, 108‐2311‐B‐001‐016‐MY3, 110‐2113‐M‐002‐023, 110‐2628‐B‐002‐049
Contributor Information
Chun‐Hua Hsu, Email: andyhsu@ntu.edu.tw.
Chinpan Chen, Email: bmchinp@ibms.sinica.edu.tw.
REFERENCES
- 1. Swartz MN. Use of antimicrobial agents and drug resistance. N Engl J Med. 1997;337:491–492. [DOI] [PubMed] [Google Scholar]
- 2. Davies J. Microbes have the last word. EMBO Rep. 2007;8:616–621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Li B, Webster TJ. Bacteria antibiotic resistance: New challenges and opportunities for implant‐associated orthopedic infections. J Orthop Res. 2018;36:22–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev. 1993;6:428–442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: No ESKAPE. J Infect Dis. 2008;197:1079–1081. [DOI] [PubMed] [Google Scholar]
- 6. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: No ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:1–12. [DOI] [PubMed] [Google Scholar]
- 7. Diekema DJ, Pfaller MA, Schmitz FJ, et al. Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis. 2001;32:S114–S132. [DOI] [PubMed] [Google Scholar]
- 8. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin‐resistant Staphylococcus aureus infections in the United States. J Am Med Assoc. 2007;298:1763–1771. [DOI] [PubMed] [Google Scholar]
- 9. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin‐resistant Staphylococcus aureus, United States, 1999–2005. Emerg Infect Dis. 2007;3:1840–1846. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Boucher HW, Corey GR. Epidemiology of methicillin‐resistant Staphylococcus aureus . Clin Infect Dis. 2008;46:S344–S349. [DOI] [PubMed] [Google Scholar]
- 11. Hanaki H, Kuwahara‐Arai K, Boyle‐Vavra S, Daum RS, Labischinski H, Hiramatsu K. Activated cell‐wall synthesis is associated with vancomycin resistance in methicillin‐resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother. 1998;42:199–209. [DOI] [PubMed] [Google Scholar]
- 12. Hiramatsu K. Vancomycin‐resistant Staphylococcus aureus: A new model of antibiotic resistance. Lancet Infect Dis. 2001;1:147–155. [DOI] [PubMed] [Google Scholar]
- 13. Utaida S, Dunman PM, Macapagal D, et al. Genome‐wide transcriptional profiling of the response of Staphylococcus aureus to cell‐wall‐active antibiotics reveals a cell‐wall‐stress stimulon. Microbiology. 2003;149:2719–2732. [DOI] [PubMed] [Google Scholar]
- 14. Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, Hiramatsu K. Two‐component system VraSR positively modulates the regulation of cell‐wall biosynthesis pathway in Staphylococcus aureus . Mol Microbiol. 2003;49:807–821. [DOI] [PubMed] [Google Scholar]
- 15. Liu C, Sun D, Zhu J, Liu W. Two‐component signal transduction systems: A major strategy for connecting input stimuli to biofilm formation. Front Microbiol. 2019;9:3279. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Stock AM, Robinson VL, Goudreau PN. Two‐component signal transduction. Annu Rev Biochem. 2000;69:183–215. [DOI] [PubMed] [Google Scholar]
- 17. Gao R, Mack TR, Stock AM. Bacterial response regulators: Versatile regulatory strategies from common domains. Trends Biochem Sci. 2007;32:225–234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. West AH, Stock AM. Histidine kinases and response regulator proteins in two‐component signaling systems. Trends Biochem Sci. 2001;26:369–376. [DOI] [PubMed] [Google Scholar]
- 19. Re SD, Schumacher J, Rousseau P, Fourment J, Ebel C, Kahn D. Phosphorylation‐induced dimerization of the FixJ receiver domain. Mol Microbiol. 1999;34:504–511. [DOI] [PubMed] [Google Scholar]
- 20. Belcheva A, Verma V, Golemi‐Kotra D. DNA‐binding activity of the vancomycin resistance associated regulator protein VraR and the role of phosphorylation in transcriptional regulation of the vraSR operon. Biochemistry. 2009;48:5592–5601. [DOI] [PubMed] [Google Scholar]
- 21. Belcheva A, Golemi‐Kotra D. A close‐up view of the VraSR two‐component system: A mediator of Staphylococcus aureus response to cell wall damage. J Biol Chem. 2008;283:12354–12364. [DOI] [PubMed] [Google Scholar]
- 22. Gardete S, Wu SW, Gill S, Tomasz A. Role of VraSR in antibiotic resistance and antibiotic‐induced stress response in Staphylococcus aureus . Antimicrob Agents Chemother. 2006;50:3424–3434. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. McCallum N, Meier PS, Heusser R, Berger‐Bachi B. Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus . Antimicrob Agents Chemother. 2011;55:1391–1402. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Dai Y, Chang W, Zhao CC, et al. VraR binding to the promoter region of agr inhibits its function in vancomycin‐intermediate Staphylococcus aureus (VISA) and heterogeneous VISA. Antimicrob Agents Chemother. 2017;61:e02740–e02716. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Galperin MY. Diversity of structure and function of response regulator output domains. Curr Opin Microbiol. 2010;13:150–159. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Kuroda M, Kuwahara‐Arai K, Hiramatsu K. Identification of the up‐ and down‐regulated genes in vancomycin‐resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method. Biochem Biophys Res Commun. 2000;269:485–490. [DOI] [PubMed] [Google Scholar]
- 27. Bourret RB. Receiver domain structure and function in response regulator proteins. Curr Opin Microbiol. 2010;13:142–149. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Leonard PG, Golemi‐Kotra D, Stock AM. Phosphorylation‐dependent conformational changes and domain rearrangements in Staphylococcus aureus VraR activation. Proc Natl Acad Sci U S A. 2013;110:8525–8530. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Tajbakhsh G, Golemi‐Kotra D. The dimerization interface in VraR is essential for induction of the cell wall stress response in Staphylococcus aureus: A potential druggable target. BMC Microbiol. 2019;19:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Donaldson LW. The NMR structure of the Staphylococcus aureus response regulator VraR DNA binding domain reveals a dynamic relationship between it and its associated receiver domain. Biochemistry. 2008;47:3379–3388. [DOI] [PubMed] [Google Scholar]
- 31. Zheng H, Cooper DR, Porebski PJ, Shabalin IG, Handing KB, Minor W. CheckMyMetal: A macromolecular metal‐binding validation tool. Acta Cryst D. 2017;73:223–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Zheng H, Chordia MD, Cooper DR, et al. Validating metal binding sites in macromolecule structures using the CheckMyMetal web server. Nat Protoc. 2014;9:156–170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Davlieva M, Shi Y, Leonard PG, et al. A variable DNA recognition site organization establishes the LiaR‐mediated cell envelope stress response of enterococci to daptomycin. Nucleic Acids Res. 2015;43:4758–4773. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Wisedchaisri G, Wu M, Rice AE, Roberts DM, Sherman DR, Hol WGJ. Structures of Mycobacterium tuberculosis DosR and DosR‐DNA complex involved in gene activation during adaptation to hypoxic latency. J Mol Biol. 2005;354:630–641. [DOI] [PubMed] [Google Scholar]
- 35. Maris AE, Sawaya MR, Kaczor‐Grzeskowiak M, et al. Dimerization allows DNA target site recognition by the NarL response regulator. Nat Struct Biol. 2002;9:771–778. [DOI] [PubMed] [Google Scholar]
- 36. He X, Wang L, Wang S. Structural basis of DNA sequence recognition by the response regulator PhoP in Mycobacterium tuberculosis . Sci Rep. 2016;6:24442. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Wemmer DE, Kern D. Beryllofluoride binding mimics phosphorylation of aspartate in response regulators. J Bacteriol. 2005;187:8229–8230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Otwinowski Z, Minor W. Processing of X‐ray diffraction data collected in oscillation mode. Methods Enzymol. 1997;276:307–326. [DOI] [PubMed] [Google Scholar]
- 39. Bunkóczi G, Echols N, McCoy AJ, Oeffner RD, Adams PD, Read RJ. Phaser.MRage: Automated molecular replacement. Acta Cryst D. 2013;69:2276–2286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Cryst D. 2010;66:486–501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Zwart PH, Afonine PV, Grosse‐kunstleve RW, et al. Automated structure solution with the PHENIX suite. Methods Mol Biol. 2008;426:419–435. [DOI] [PubMed] [Google Scholar]
- 42. Schrödinger L, Delano W. PyMOL. Version 2.4, 2020. Available from: http://www.pymol.org/pymol.
- 43. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6:277–293. [DOI] [PubMed] [Google Scholar]
- 44. Johnson BA, Blevins RA. NMR view: A computer program for the visualization and analysis of NMR data. J Biomol NMR. 1994;4:603–614. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Table S1 Thermal stability of VraRC, VraR, and BeF3 − activated VraR in sodium phosphate buffer at the different pH values monitored at 222 nm by CD spectroscopy.
Table S2. DNA sequences used for binding and co‐crystallization with VraRC. Potential binding nucleotide sites to the DNA binding domain identified from the previous study are underlined.
Table S3. Data collection and structural refinement statistics for VraRC, VraRC–DNA complex and VraRN. Data were collected on a single crystal for each dataset.
Figure S1 The purified VraRC and VraR on 15% SDS‐PAGE. Lane 1, unlabeled VraRC; lane 2, 15N13C2H VraRC; lane 3, VraR; lane 4, 5N13C2H VraR.
Figure S2 The AUC‐SV profiles showing the dimer formation of VraR with BeF3 − activation. The c(S) distribution of inactive VraR is at 2.8 S and BeF3 − activated VraR at 3.45 S.
Figure S3 (A) Far‐UV CD spectra for VraRC, VraR and VraR activated by BeF3 − in sodium phosphate buffer at pH 6 at 25°C. (B) The thermal unfolding experiments of VraRC, inactive and active VraR are monitored at 222 nm reveal melting temperatures of 58.30, 48.82, and 52.17°C.
Figure S4 The crystal structure of VraRC contains residues Glu143 to Gln209 and all α‐helices are labeled accordingly.
Figure S5 2D 1H–15N HSQC spectra for VraRC at pH 7.0 and 310 K. All backbone resonances were identified and labeled except for the amide resonances of Lys139 and Asn165. The side chain NH2 resonances of Asn and Gln are connected by blue horizontal lines.
Figure S6 The electrostatic potential surface of two VraRC subunits from the VraRC–DNA complex having a predominantly positive charge favorable for DNA interactions. The electrostatic potential was calculated with Pymol plugin APBS, showing red for negative and blue for positive surface.
Figure S7 In the VraRC–DNA complex, 4 Mg2+ ions (green spheres) are present near DNA. Two Mg2+ ions having no direct interactions with DNA are in black circles. Six water molecules coordinating each Mg2+ ion are in red spheres.
Figure S8 Structural overlay of inactive VraR (PDB ID: 4GVP) (yellow) toward a single subunit of VraRC (blue) from the R1‐DNA complex. All 11 residues binding to R1‐DNA from the VraRC–DNA complex are depicted as sticks on inactive VraR to show the probability of a binding pattern as the α9 helix fits into the major groove DNA.
